The study results revealed that INC424 provided a statistically significant reduction in spleen size in patients with primary MF, post-polycythemia vera myelofibrosis (PPV-MF) or post-essential thrombocythemia myelofibrosis (PET-MF).
Mantecorp, controlled by Brazil’s Mantegazza family, is based in Rio de Janeiro state. Mantecorp has a portfolio of prescription and non-prescription drugs, as well as a line of
The Japan patent covers Rexahn’s preclinical compound RX-0047 and a method of inhibiting the expression of HIF-1 in human cells or tissues. HIF-1, a human protein is involved
Theobromine, a metabolite of caffeine, has been used as a vasodilator (a blood vessel widener), a diuretic (urination aid) and heart stimulant. Theobromine has been shown to inhibit
Alferon N Injection is Hemispherx’s natural FDA approved interferon injection product for a category of sexually transmitted diseases in Argentina with an option for other Latin American countries
Glenmark‘s extended-release Felodipine tablets are available in strengths of 2.5 mg, 5 mg and 10 mg and are indicated for the treatment of hypertension. Glenmark will commence marketing
Pristine Pharma, a wholly owned subsidiary of Michelex, is planning to produce cough syrups, pain relievers, nasal sprays and other liquid OTC medicines under store brand labels, and
The two grants totaling were awarded to ExonHit by the US Secretary of Health and Human Services to support its Alzheimer’s disease and oncology research and development projects.
The Phase I trial for AC430 is a two part, placebo-controlled, single ascending, and multiple ascending dose trial in healthy volunteers. In the trial, AC430 will be administered
Eisai has submitted an application to the Japanese Ministry of Health, Labour and Welfare on 28 April 2010, seeking approval of additional twice-daily dosage and administration of Pariet
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.